BioCryst Pharmaceuticals Inc (BCRX)
7.485
+0.18
(+2.53%)
USD |
NASDAQ |
Nov 21, 16:00
7.485
0.00 (0.00%)
After-Hours: 16:06
BioCryst Pharmaceuticals Price: 7.485 for Nov. 21, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 20, 2024 | 7.16 | 7.505 | 7.090 | 7.30 | 1.641M |
Nov 19, 2024 | 7.06 | 7.32 | 7.00 | 7.21 | 1.591M |
Nov 18, 2024 | 7.05 | 7.135 | 6.92 | 7.06 | 1.713M |
Nov 15, 2024 | 7.50 | 7.52 | 6.93 | 7.03 | 2.831M |
Nov 14, 2024 | 7.68 | 7.74 | 7.40 | 7.45 | 1.877M |
Nov 13, 2024 | 7.92 | 8.00 | 7.63 | 7.64 | 1.308M |
Nov 12, 2024 | 8.16 | 8.24 | 7.780 | 7.82 | 1.696M |
Nov 11, 2024 | 7.87 | 8.25 | 7.87 | 8.19 | 1.826M |
Nov 08, 2024 | 7.55 | 7.84 | 7.52 | 7.78 | 1.573M |
Nov 07, 2024 | 7.70 | 7.88 | 7.505 | 7.67 | 2.337M |
Nov 06, 2024 | 7.19 | 7.74 | 7.10 | 7.73 | 3.502M |
Nov 05, 2024 | 7.38 | 7.439 | 7.03 | 7.055 | 4.088M |
Nov 04, 2024 | 7.77 | 7.96 | 6.845 | 7.35 | 11.28M |
Nov 01, 2024 | 8.03 | 8.44 | 8.00 | 8.43 | 2.888M |
Oct 31, 2024 | 8.31 | 8.38 | 7.99 | 8.01 | 1.963M |
Oct 30, 2024 | 8.02 | 8.37 | 7.97 | 8.37 | 1.439M |
Oct 29, 2024 | 8.11 | 8.17 | 8.00 | 8.12 | 1.120M |
Oct 28, 2024 | 7.99 | 8.225 | 7.98 | 8.15 | 1.484M |
Oct 25, 2024 | 8.19 | 8.23 | 7.95 | 7.95 | 1.443M |
Oct 24, 2024 | 8.08 | 8.235 | 7.97 | 8.18 | 1.829M |
Oct 23, 2024 | 7.92 | 8.115 | 7.88 | 8.06 | 1.702M |
Oct 22, 2024 | 7.44 | 8.17 | 7.44 | 7.95 | 2.939M |
Oct 21, 2024 | 7.58 | 7.655 | 7.45 | 7.52 | 1.598M |
Oct 18, 2024 | 7.54 | 7.63 | 7.44 | 7.62 | 1.265M |
Oct 17, 2024 | 7.59 | 7.59 | 7.42 | 7.49 | 1.099M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.60
Minimum
Mar 18 2020
19.76
Maximum
Feb 16 2022
8.791
Average
7.94
Median
May 11 2022
Price Benchmarks
AIM ImmunoTech Inc | 0.2115 |
Perspective Therapeutics Inc | 2.99 |
Protalix BioTherapeutics Inc | 1.67 |
Electromed Inc | 27.87 |
Armata Pharmaceuticals Inc | 2.10 |
Price Related Metrics
PS Ratio | 3.723 |
Earnings Yield | -8.15% |
Market Cap | 1.550B |